Share Twitter LinkedIn Facebook Email Mohammad Jahanzeb, MD, FACP, explains what he might do in sequencing therapies as a result of Keynote 189 and Keynote 42 presented at the 2018 Annual Meeting Annual Meeting. Advertisement
ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read